These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32737469)
1. Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52. Wang WL; Jiang ZR; Hu C; Chen C; Hu ZQ; Wang AL; Wang L; Liu J; Wang WC; Liu QS Acta Pharmacol Sin; 2021 Apr; 42(4):633-640. PubMed ID: 32737469 [TBL] [Abstract][Full Text] [Related]
2. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel non-ATP-competitive protein kinase inhibitor of PGK1 from marine nature products. Wang Y; Sun L; Yu G; Qi X; Zhang A; Lu Z; Li D; Li J Biochem Pharmacol; 2021 Jan; 183():114343. PubMed ID: 33212041 [TBL] [Abstract][Full Text] [Related]
4. PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes. Gou R; Hu Y; Liu O; Dong H; Gao L; Wang S; Zheng M; Li X; Lin B Front Oncol; 2021; 11():682461. PubMed ID: 34277429 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphoglycerate kinase 1 attenuates autoimmune myocarditis by reprogramming CD4+ T cell metabolism. Lu Y; Zhao N; Wu Y; Yang S; Wu Q; Dong Q; Du Y Cardiovasc Res; 2023 Jun; 119(6):1377-1389. PubMed ID: 36726197 [TBL] [Abstract][Full Text] [Related]
6. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway. Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252 [TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nie H; Ju H; Fan J; Shi X; Cheng Y; Cang X; Zheng Z; Duan X; Yi W Nat Commun; 2020 Jan; 11(1):36. PubMed ID: 31911580 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of phosphoglycerate kinase 1 by shRNA sensitizes U251 xenografts to radiotherapy. Cheng YJ; Ding H; Du HQ; Yan H; Zhao JB; Zhang WB; Zou YJ; Liu HY; Xiao H Oncol Rep; 2014 Oct; 32(4):1513-20. PubMed ID: 25175369 [TBL] [Abstract][Full Text] [Related]
9. Sulforaphane suppresses cell proliferation and induces apoptosis in glioma via the ACTL6A/PGK1 axis. Peng ZT; Hu R; Fu JY Toxicol Mech Methods; 2024 Jun; 34(5):507-516. PubMed ID: 38221767 [TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo. He Y; Luo Y; Huang L; Zhang D; Hou H; Liang Y; Deng S; Zhang P; Liang S Eur J Med Chem; 2024 Mar; 267():116209. PubMed ID: 38354523 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Yang Z; Zhang SL; Hu X; Tam KY Eur J Pharmacol; 2018 Nov; 838():41-52. PubMed ID: 30213498 [TBL] [Abstract][Full Text] [Related]
12. The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma. Chen W; Jia W; Wu C; Chen L; Sun K; Wang J; Ding B; Liu N; Xu R Front Oncol; 2021; 11():644492. PubMed ID: 34221965 [TBL] [Abstract][Full Text] [Related]
13. GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo. Zhou X; Shen F; Ma P; Hui H; Pei S; Chen M; Wang Z; Zhou W; Jin B Mol Med Rep; 2015 Oct; 12(4):5641-6. PubMed ID: 26238593 [TBL] [Abstract][Full Text] [Related]
14. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells. Fukushi A; Kim HD; Chang YC; Kim CH Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431 [TBL] [Abstract][Full Text] [Related]
15. Targeting the Glycolytic Enzyme PGK1 to Inhibit the Warburg Effect: A New Strategy for Keloid Therapy. Wang P; Wang Q; Yang X; An Y; Wang J; Nie F; Pan B; Bi H; Qin Z Plast Reconstr Surg; 2023 Jun; 151(6):970e-980e. PubMed ID: 36728674 [TBL] [Abstract][Full Text] [Related]
16. LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1. Liang J; Liu C; Xu D; Xie K; Li A J Transl Med; 2022 Feb; 20(1):80. PubMed ID: 35123484 [TBL] [Abstract][Full Text] [Related]
17. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
18. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Dixit D; Ghildiyal R; Anto NP; Sen E Cell Death Dis; 2014 May; 5(5):e1212. PubMed ID: 24810048 [TBL] [Abstract][Full Text] [Related]
19. Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells. Jin C; Zhu X; Wu H; Wang Y; Hu X J Biol Chem; 2020 May; 295(19):6425-6446. PubMed ID: 32217690 [TBL] [Abstract][Full Text] [Related]
20. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis. Zhang Y; Yu G; Chu H; Wang X; Xiong L; Cai G; Liu R; Gao H; Tao B; Li W; Li G; Liang J; Yang W Mol Cell; 2018 Jul; 71(2):201-215.e7. PubMed ID: 30029001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]